Top Markets
#1 Threshold Network Threshold Network +50.17%
#2 TENDIES TENDIES +45.61%
#3 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#4 Kinetiq Kinetiq +16.51%
#5 OSK OSK +16.24%
#6 Mubarak Mubarak +15.58%
#7 Magma Finance Magma Finance +12.86%
#8 Ape and Pepe Ape and Pepe +12.62%
#9 MultiversX MultiversX +11.97%
#10 Maple Finance Maple Finance +11.37%
Coin of the day
Threshold Network Threshold Network
Settings
Language
ENGLISH
Currency
USD
Theme
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Rank in Stocks #17186
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Share Price
$2.17
Market Cap
$249.58M
Change (1 day)
-1.67%
Change (1 year)
96.34%
Country
CA
Trade Cardiol Therapeutics Inc. (CRDL)

Category

Healthcare
P/S ratio for Cardiol Therapeutics Inc. (CRDL)
P/S ratio as of 2026 TTM: 0
According to Cardiol Therapeutics Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Cardiol Therapeutics Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
7.75 -
IN
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH